ERN-EYE joint webinar with ERN Genturis, the ERN dedicated to Genetic Tumour Risk Syndromes.
Connection link will be sent shortly before the event. Registration is open until 3rd February, 12 am.
Click here to register to the webinar
1) Overview of NF1 & NF2, recommendation, surveillance and new diagnostic criteria, Eric Legius, Leuven University Hospital, Belgium.
2) Ophthalmological aspects, retinal imaging & OCT of NF1 & NF2, and paediatric specificities of the care, Dominique Brémond-Gignac and Matthieu Robert, Hôpital Necker-Enfants Malades, Paris.
3) Molecular aspects of NF-1 and NF-2 and genetic testing, Kathleen Claes, Ghent University Hospital, Belgium.
4) Patient testimony, added value of the early genetic testing, Claas Röhl, Austrian center of expertise for Neurofibromatosis, Vienna, Austria.
More information about the speakers.